Alkermes
ALKS
#3093
Rank
A$7.33 B
Marketcap
A$44.44
Share price
0.75%
Change (1 day)
-9.59%
Change (1 year)

Revenue for Alkermes (ALKS)

Revenue in 2025 (TTM): A$2.37 Billion

According to Alkermes's latest financial reports the company's current revenue (TTM ) is A$2.29 Billion. In 2024 the company made a revenue of A$2.50 Billion an increase over the revenue in the year 2023 that were of A$2.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alkermes from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$2.37 B-5.26%
2024 A$2.50 B2.57%
2023 A$2.44 B49.44%
2022 A$1.63 B0.91%
2021 A$1.61 B19.85%
2020 A$1.35 B-19.23%
2019 A$1.67 B7.67%
2018 A$1.55 B34.24%
2017 A$1.15 B11.85%
2016 A$1.03 B19.94%
2015 A$0.86 B14.07%
2014 A$0.75 B
2012 A$0.52 B72.34%
2011 A$0.30 B76.89%
2010 A$0.17 B-16.24%
2009 A$0.20 B-58.23%
2008 A$0.48 B76.02%
2007 A$0.27 B-4.17%
2006 A$0.29 B56.17%
2005 A$0.18 B107.9%
2004 A$89.38 M88.32%
2003 A$47.46 M-43.79%
2002 A$84.44 M-16.06%
2001 A$0.10 B26.31%
2000 A$79.64 M110.38%
1999 A$37.85 M-49.8%
1998 A$75.41 M75.55%
1997 A$42.96 M86.42%
1996 A$23.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
A$0.17 B-92.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$72.31 B 3,057.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$138.73 B 5,957.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$94.52 B 4,027.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$87.51 B 3,720.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$25.25 B 1,002.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
A$0.12 B-94.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$71.54 B 3,023.90%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
A$84.86 B 3,605.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland